Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 205.63

+1.0%

11:29 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: celeryroot.com who wrote (29598)	12/13/1999 8:43:00 PM
From: Henry Niman	Read Replies (1) of 32384

They were asking for approval on all indications, but the key is that fact that Targretin will probably be on pharmacy shelves in Feb/March, which paves the way for huge off label sales if the interim breast cancer data is positive. Taxol was initially approved for ovarian cancer, but its breast cancer sales, prior to approval for breast cancer, were very significant.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next